@article{86d70aaf26c64399a181550cf2acca54,
title = "Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎",
keywords = "hemoglobin, ruxolitinib, adult, aged, anemia, Article, drug efficacy, drug response, female, high risk patient, human, intermediate risk patient, International Prognostic Scoring System, leukocyte count, major clinical study, male, multicenter study, myelofibrosis, overall survival, phenotype, platelet count, polycythemia vera, priority journal, probability, prognosis, scoring system, survival rate, thrombocythemia, thrombocytopenia, validity",
author = "F. Palandri and G.A. Palumbo and A. Iurlo and N. Polverelli and G. Benevolo and M. Breccia and E. Abruzzese and M. Tiribelli and M. Bonifacio and A. Tieghi and A. Isidori and B. Martino and N. Sgherza and M. D'Adda and M. Bergamaschi and M. Crugnola and F. Cavazzini and C. Bosi and G. Binotto and G. Auteri and R. Latagliata and A. Ibatici and L. Scaffidi and D. Penna and D. Cattaneo and F. Soci and M. Trawinska and D. Russo and A. Cuneo and G. Semenzato and {Di Raimondo}, F. and F. Aversa and R.M. Lemoli and F. Heidel and M.L.B. Reggiani and D. Bartoletti and M. Cavo and L. Catani and N. Vianelli",
note = "cited By 0",
year = "2018",
doi = "10.1053/j.seminhematol.2018.05.013",
language = "English",
volume = "55",
pages = "248--255",
journal = "Seminars in Hematology",
issn = "0037-1963",
publisher = "W.B. Saunders Ltd",
number = "4",
}